Search Results - "BASU, SUPRATIK"

Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA by Facon, Thierry, Cook, Gordon, Usmani, Saad Z., Hulin, Cyrille, Kumar, Shaji, Plesner, Torben, Touzeau, Cyrille, Bahlis, Nizar J., Basu, Supratik, Nahi, Hareth, Goldschmidt, Hartmut, Quach, Hang, Mohty, Mohamad, Venner, Christopher P., Weisel, Katja, Raje, Noopur, Hebraud, Benjamin, Belhadj-Merzoug, Karim, Benboubker, Lotfi, Decaux, Olivier, Manier, Salomon, Caillot, Denis, Ukropec, Jon, Pei, Huiling, Van Rampelbergh, Rian, Uhlar, Clarissa M., Kobos, Rachel, Zweegman, Sonja

“…In the phase 3 MAIA study of patients with transplant-ineligible newly diagnosed multiple myeloma (NDMM), daratumumab plus lenalidomide/dexamethasone (D-Rd)…”
Get full text

The UPTAKE study: a cross-sectional survey examining the insights and beliefs of the UK population on COVID-19 vaccine uptake and hesitancy by Sethi, Sonika, Kumar, Aditi, Mandal, Anandadeep, Shaikh, Mohammed, Hall, Claire A, Kirk, Jeremy M W, Moss, Paul, Brookes, Matthew J, Basu, Supratik

“…ObjectiveA key challenge towards a successful COVID-19 vaccine uptake is vaccine hesitancy. We examine and provide novel insights on the key drivers and…”
Get full text

Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohort by Maouche, Nadjoua, Kishore, Bhuvan, Bhatti, Zara, Basu, Supratik, Karim, Farheen, Sundararaman, Sharadha, Collings, Freya, Tseu, Bing, Leary, Heather, Ryman, Noel, Reddy, Udaya, Vallance, Grant D, Kothari, Jaimal, Ramasamy, Karthik

“…The combination of panobinostat, bortezomib and dexamethasone (PanBorDex) is available as a treatment option for relapsed refractory multiple myeloma (RRMM)…”
Get full text

Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma by Agarwal, Gaurav, Moore, Sally, Sadler, Ross, Varghese, Sherin, Turner, Alison, Chen, Lucia Y, Larham, Jemma, Gray, Nathanael, Carty, Oluremi, Barrett, Joe, Koshiaris, Constantinos, Kothari, Jaimal, Bowcock, Stella, Oppermann, Udo, Gamble, Vicky, Cook, Gordon, Kyriakou, Chara, Drayson, Mark, Basu, Supratik, McDonald, Sarah, McKinley, Shelagh, Gooding, Sarah, Javaid, Muhammad K, Ramasamy, Karthik

Get full text

Outcomes of anti-CD38 isatuximab plus pomalidomide and dexamethasone in five relapsed myeloma patients with prior exposure to anti-C38 daratumumab: case series by Djebbari, Faouzi, Poynton, Matt, Sangha, Gina, Anderson, Laura, Maddams, Rebecca, Eyre, Toby A., Vallance, Grant, Basu, Supratik, Ramasamy, Karthik

“…Objectives: Daratumumab is the first anti-CD38 monoclonal antibody (Mab) used to treat myeloma in the newly diagnosed setting and in the relapsed setting…”
Get full text

Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis by Hutchison, Colin A, Bradwell, Arthur R, Cook, Mark, Basnayake, Kolitha, Basu, Supratik, Harding, Stephen, Hattersley, John, Evans, Neil D, Chappel, Mike J, Sampson, Paul, Foggensteiner, Lukas, Adu, Dwomoa, Cockwell, Paul

“…Extended hemodialysis using a high cut-off dialyzer (HCO-HD) removes large quantities of free light chains in patients with multiple myeloma. However, the…”
Get full text

The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond by Sethi, Sonika, Kumar, Aditi, Mandal, Anandadeep, Shaikh, Mohammed, Hall, Claire A, Kirk, Jeremy M W, Moss, Paul, Brookes, Matthew J, Basu, Supratik

“…Developing a safe and effective vaccine will be the principal way of controlling the COVID-19 pandemic. However, current COVID-19 vaccination trials are not…”
Get full text

Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma by Mateos, Maria-Victoria, Rigaudeau, Sophie, Basu, Supratik, Spicka, Ivan, Schots, Rik, Wrobel, Tomasz, Cook, Gordon, Beksac, Meral, Gries, Katharine S, Kudva, Anupa, Tromp, Brenda, Van Rampelbergh, Rian, Pei, Huiling, Wroblewski, Susan, Carson, Robin, Delioukina, Maria, White, Darrell

“…Introduction Two phase 3 studies demonstrated superior efficacy of intravenous daratumumab (DARA IV) plus bortezomib/melphalan/prednisone (ALCYONE) or…”
Get full text

Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: Initial results of a UK-wide real-world study by Djebbari, Faouzi, Rampotas, Alexandros, Vallance, Grant, Panitsas, Fotios, Basker, Nanda, Sangha, Gina, Salhan, Beena, Karim, Farheen, Firas, Al-Kaisi, Gudger, Amy, Ngu, Loretta, Poynton, Matt, Lam, Ho Pui Jeff, Morgan, Lowri, Yang, Laura, Young, Jennifer, Walker, Mairi, Tsagkaraki, Ismini, Anderson, Laura, Chauhan, Saleena Rani, Maddams, Rebecca, Soutar, Richard, Triantafillou, Margarita, Prideaux, Steve, Obeidalla, Abubaker, Eyre, Toby A., Bygrave, Ceri, Basu, Supratik, Ramasamy, Karthik

“…There are no real-world data describing infection morbidity in relapsed/refractory myeloma (RRMM) patients treated with anti-CD38 isatuximab in combination…”
Get full text

COVID-19 seroprevalence after the first UK wave of the pandemic and its association with the physical and mental wellbeing of secondary care healthcare workers by Sethi, Sonika, Manuelpillai, Natasha, Mandal, Anandadeep, Simpson, Olivia, Morrissey, Hana, Ball, Patrick, Sharrod-Cole, Hayley, Ford, Clare, Whittaker, Anna C., Drayson, Mark, Race, Adam, Bateman, James, Basu, Supratik, Cotton, James

“…To determine the seroprevalence of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) antibody status amongst healthcare workers (HCWs) working…”
Get full text

Haematological manifestations of COVID‐19: From cytopenia to coagulopathy by Agbuduwe, Charles, Basu, Supratik

“…Emerging data from the management of patients with coronavirus disease 2019 (COVID‐19) suggests multi‐systemic involvement, including the hemopoietic system…”
Get full text

Efficacy of Isatuximab With Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of a UK‐Wide Real‐World Dataset by Djebbari, Faouzi, Rampotas, Alexandros, Vallance, Grant, Panitsas, Fotios, Basker, Nanda, Sangha, Gina, Salhan, Beena, Karim, Farheen, Al‐Kaisi, Firas, Gudger, Amy, Ngu, Loretta, Poynton, Matt, Lam, Ho Pui Jeff, Morgan, Lowri, Yang, Laura, Young, Jennifer, Walker, Mairi, Tsagkaraki, Ismini, Anderson, Laura, Chauhan, Saleena Rani, Maddams, Rebecca, Soutar, Richard, Triantafillou, Margarita, Prideaux, Steve, Obeidalla, Abubaker, Bygrave, Ceri, Basu, Supratik, Ramasamy, Karthik

“…Real‐world data on the efficacy and tolerability of isatuximab with pomalidomide and dexamethasone (IsaPomDex) in relapsed/refractory myeloma patients have not…”
Get full text

Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma by Terpos, Evangelos, Rezvani, Katayoun, Basu, Supratik, Milne, Alison E., Rose, Peter E., Scott, Geoffrey L., Rahemtulla, Amin, Samson, Diana, Apperley, Jane F.

“…:  Autologous (ASCT) and allogeneic stem cell transplantations (alloBMT) are well‐established therapies for multiple myeloma. However, patients continue to…”
Get full text

Antibody-mediated pure red cell aplasia in a dialysis patient receiving darbepoetin alfa as the sole erythropoietic agent by Jacob, Abraham, Sandhu, Kanwaljit, Nicholas, Johann, Jones, Helen, Odum, Jonathan, Rylance, Paul, Carmichael, Paul, Jackson, Maurice, Handa, Sunil, Macwhannell, Alan, Basu, Supratik, Wahid, Faisal, Casadevall, Nicole, Mufti, Ghulam, Macdougall, Iain

Get full text

Structural study of graben within the Margaritifer Terra region of Mars by Basu, Supratik, Dasgupta, Ashmita, Kundu, Abhik, Dasgupta, Dipayan

“…The surface of Mars preserves a variety of structural and geomorphic features such as wrinkle ridges, graben, lobate scarps, impact basins, paleochannels etc.,…”
Get full text

Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma by Facon, Thierry, Kumar, Shaji, Plesner, Torben, Orlowski, Robert Z, Moreau, Philippe, Bahlis, Nizar, Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, Goldschmidt, Hartmut, O’Dwyer, Michael, Perrot, Aurore, Venner, Christopher P, Weisel, Katja, Mace, Joseph R, Raje, Noopur, Attal, Michel, Tiab, Mourad, Macro, Margaret, Frenzel, Laurent, Leleu, Xavier, Ahmadi, Tahamtan, Chiu, Christopher, Wang, Jianping, Van Rampelbergh, Rian, Uhlar, Clarissa M, Kobos, Rachel, Qi, Ming, Usmani, Saad Z

“…The addition of daratumumab to lenalinomide and dexamethasone in patients with previously untreated myeloma who were not eligible for high-dose chemotherapy…”
Get full text

Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial by Facon, Thierry, Kumar, Shaji K, Plesner, Torben, Orlowski, Robert Z, Moreau, Philippe, Bahlis, Nizar, Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, Goldschmidt, Hartmut, O'Dwyer, Michael, Perrot, Aurore, Venner, Christopher P, Weisel, Katja, Mace, Joseph R, Raje, Noopur, Tiab, Mourad, Macro, Margaret, Frenzel, Laurent, Leleu, Xavier, Ahmadi, Tahamtan, Wang, Jianping, Van Rampelbergh, Rian, Uhlar, Clarissa M, Tromp, Brenda, Delioukina, Maria, Vermeulen, Jessica, Usmani, Saad Z

“…In the primary analysis of the phase 3 MAIA trial (median follow-up 28·0 months), a significant improvement in progression-free survival was observed with…”
Get full text

The role of pre-existing faults and fractures in shaping polygonal impact craters and its tectonic implications in the southern Margaritifer Terra region, Mars by Basu, Supratik, Dasgupta, Nilanjan, Kundu, Abhik, Bhattacharya, Satadru, Dasgupta, Dipayan

“…The presence of polygonal-shaped craters, i.e., craters with complete or incomplete polygonal rims along with circular or elliptical outlines, on the surface…”
Get full text

Critical Care Support Improves Outcome of Haematology Admissions: A Retrospective Analysis during Covid Pandemic from UK by Whitmill, Richard, Basu, Supratik, Mandal, Anandadeep, Usung, Ubon, Babai, Arwa, Mohamed, Mustafa

“…Background Long held assumptions of poor prognoses for patients with haematological disease have meant that intensivists are often reluctant to admit them to…”
Get full text

An in Depth Analysis of Factors Contributing to Diagnostic Delay in Myeloma: A Retrospective UK Study of Patients Journey from Primary Care to Specialist Secondary Care by Hossain, Md Imran, Hampson, Peter, Nowell, Craig, Khan, Shamshad, Sen, Ranjoy, Sundararaman, Sharadha, Adiyodi, Jagdish, Basu, Supratik

“…Introduction Patients with Multiple Myeloma (MM) often have a significant delay between onset of symptoms and diagnosis of disease. As a result, a significant…”
Get full text